%D9%81%D9%8A%D9%86%D9%88%D8%A8%D8%A7%D8%B1%D8%A8%D9%8A%D8%AA%D8%A7%D9%84FenobarbitalCategory:PhenobarbitalFenobarbitalFfenobarbitalPhenobarbitalPhenobarbitalPhenobarbitalFenobarbitalFenobarbital%D9%81%D9%86%D9%88%D8%A8%D8%A7%D8%B1%D8%A8%DB%8C%D8%AA%D8%A7%D9%84FenobarbitaaliPh%C3%A9nobarbitalFenobarbital%D7%A4%D7%A0%D7%95%D7%91%D7%A8%D7%91%D7%99%D7%98%D7%9C%E0%A4%AB%E0%A5%87%E0%A4%A8%E0%A4%BE%E0%A4%AC%E0%A4%BE%E0%A4%B0%E0%A5%8D%E0%A4%AC%E0%A4%BF%E0%A4%9F%E0%A5%89%E0%A4%B2FenobarbitalFenobarbit%C3%A1l%D4%BC%D5%B5%D5%B8%D6%82%D5%B4%D5%AB%D5%B6%D5%A1%D5%ACFenobarbitalFenobarbital%E3%83%95%E3%82%A7%E3%83%8E%E3%83%90%E3%83%AB%E3%83%93%E3%82%BF%E3%83%BC%E3%83%AB%ED%8E%98%EB%85%B8%EB%B0%94%EB%A5%B4%EB%B9%84%ED%83%88%D0%A4%D0%B5%D0%BD%D0%BE%D0%B1%D0%B0%D1%80%D0%B1%D0%B8%D1%82%D0%BE%D0%BDFenobarbitalFenobarbitalFenobarbital%E0%AC%AB%E0%AC%BF%E0%AC%A8%E0%AD%8B%E0%AC%AC%E0%AC%BE%E0%AC%B0%E0%AD%8D%E0%AC%AC%E0%AC%BF%E0%AC%9F%E0%AC%BE%E0%AC%B2FenobarbitalFenobarbitalFenobarbital%D0%A4%D0%B5%D0%BD%D0%BE%D0%B1%D0%B0%D1%80%D0%B1%D0%B8%D1%82%D0%B0%D0%BBFenobarbitalFenobarbitalFenobarbitalFenobarbital%D0%A4%D0%B5%D0%BD%D0%BE%D0%B1%D0%B0%D1%80%D0%B1%D1%96%D1%82%D0%B0%D0%BBPhenobarbital%E8%8B%AF%E5%B7%B4%E6%AF%94%E5%A6%A5Q407241
about
sameAs
Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal SeizuresComparison of the Breast Tumor MicroenvironmentDetection of Luminal and Mucosa-associated Microbiome in Healthy Controls vs. Local and Systemic InflammationChildhood Convulsive Status Epilepticus Management In A Resource Limited SettingCAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCERUltrasound-guided Percutaneous Biliary Drainage With Primary Metal Implantation by Endoscopic Luminal GuidanceNeoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast CancerEfficacy of Keppra for Neonatal SeizuresPharmacokinetics of Antiepileptics in Patients on CRRTPolytetrafluoroethylen (PTFE) Vascular Prostheses With Heparin Bonded Luminal Surfaces vs Crude ePTFELevetiracetam Treatment of Neonatal SeizuresImproving Outcomes in Neonatal Abstinence SyndromeAlbumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast CancerAlcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or KetamineSelective Treatment According to Molecular Subtype of Prostate CancerClonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence SyndromePhenobarbital for Severe Acute Alcohol Withdrawal SyndromeA Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular BlockagesNiraparib Plus Aromatase Inhibitors for Luminal-like(HER2-negative,ER-positive) and gBRCA or HDR-positive Metastatic Breast Cancer(LUZERN)NX in Luminal B Breast Cancer Patients After Neoadjuvant ChemotherapyTumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast CancerEfficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures
P4844
Quinoline: conversion to a mutagen by human and rodent liverInhalation pharmacokinetics of 1,2-dichloroethane after different dietary pretreatments of male Sprague-Dawley ratsPurification and characterization of cytochrome P-450 isozymes from phenobarbital-induced adult hen liverMetabolism and toxicity of styreneVinyl chloride hepatotoxicity and its alteration by modifiers of hepatic biotransformation in the ratIn Vitro Tests For Workplace Cocarcinogens, Final ReportInfluence Of Industrial Poisons And Drugs On The Activity Of Microsomal EnzymesEffects Of Carcinogens, Mutagens, And Teratogens On Nonhuman Species (Aquatic Animals)Inhibition of Metabolic Cooperation in V79 Cells: Potential Correlations with Tumor PromotionTopological virtual screening: a way to find new anticonvulsant drugs from chemical diversitySynthesis and anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinonesSynthesis and anticonvulsant activity of 2-benzylglutarimidesHologram QSAR model for the prediction of human oral bioavailability.1-(Naphthylalkyl)-1H-imidazole derivatives, a new class of anticonvulsant agents.Metabolism of 3-(p-chlorophenyl)pyrrolidine. Structural effects in conversion of a prototype gamma-aminobutyric acid prodrug to lactam and gamma-aminobutyric acid type metabolites.Drugs as allergens: the molecular basis of IgE binding to thiopentone.Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 1. Hydrazines.Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.N-imidazolylchroman-4-ones, N-imidazolyl-1-tetralones, and their alcohols as hypolipemic agents raising high-density lipoproteins.Synthesis and structural studies of aza analogues of functionalized amino acids: new anticonvulsant agents.Design and evaluation of affinity labels of functionalized amino acid anticonvulsants.Preparation and anticonvulsant activity of a series of functionalized alpha-aromatic and alpha-heteroaromatic amino acids.2-Phenyl-3H-imidazo[4,5-b]pyridine-3-acetamides as non-benzodiazepine anticonvulsants and anxiolytics.Synthesis and evaluation of N-(phenylacetyl)trifluoromethanesulfonamides as anticonvulsant agents.Preparation and anticonvulsant activity of a series of functionalized alpha-heteroatom-substituted amino acids.Synthesis and anticonvulsant activity of 2-iminohydantoins.Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).Synthesis and anticonvulsant activity of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines.Discovery of N-(2,6-dimethylphenyl)-substituted semicarbazones as anticonvulsants: hybrid pharmacophore-based design.Accumulation of drugs by guinea pig isolated atria. Quantitative correlations.Synthesis and anticonvulsant activity of 4-(2-(2,6-dimethylphenylamino)-2-oxoethylamino)-N-(substituted)butanamides: a pharmacophoric hybrid approach.Anticonvulsant activity of piperidinol and (dialkylamino)alkanol esters.A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.2,4-Dihydro-3H-1,2,4-triazol-3-ones as anticonvulsant agents.Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.QSAR model for drug human oral bioavailability.Prediction of drug solubility from Monte Carlo simulations.Anticonvulsant activity of some 4-aminobenzanilides.The pharmacophore hypotheses of IKr potassium channel blockers: novel class III antiarrhythmic agents
P921
description
Arzneistoff aus der Gruppe der Barbiturate
@de
Medikamentu barbiturikoa, epilepsia eta konbultsioen kontra eta hipnotiko moduan erabilia
@eu
barbitúrico anticonvulsivo
@es
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
name
Fenobarbitaali
@fi
Fenobarbital
@cs
Fenobarbital
@eu
Fenobarbital
@gl
Fenobarbital
@hr
Fenobarbital
@id
Fenobarbital
@it
Fenobarbital
@ms
Fenobarbital
@nb
Fenobarbital
@nl
type
label
Fenobarbitaali
@fi
Fenobarbital
@cs
Fenobarbital
@eu
Fenobarbital
@gl
Fenobarbital
@hr
Fenobarbital
@id
Fenobarbital
@it
Fenobarbital
@ms
Fenobarbital
@nb
Fenobarbital
@nl
altLabel
1400-48-2
@fr
5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione
@en
5-Ethyl-5-phenylbarbituric acid
@cy
5-Ethyl-5-phenylbarbituric acid
@en
5-Phenyl-5-ethylbarbituric acid
@cy
5-Phenyl-5-ethylbarbituric acid
@en
5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
@en
5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione
@en
50-06-6
@fr
54840-95-8
@fr
prefLabel
Fenobarbitaali
@fi
Fenobarbital
@cs
Fenobarbital
@eu
Fenobarbital
@gl
Fenobarbital
@hr
Fenobarbital
@id
Fenobarbital
@it
Fenobarbital
@ms
Fenobarbital
@nb
Fenobarbital
@nl